← Leaderboards
Patrick Y Lu
Sirnaomics, Inc.
$747,298
Attributed
$747,298
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $269.3K · FY2008–10$500K$375K$250K$125K$0
'08
'09
'10
Funding mix
By agency
NIH$747,298 · 3
By mechanism
R43$747,298 · 3
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Rna Interference”
- Norbert Perrimon · Harvard Medical School$46,131,269
- Stuart L Schreiber · Harvard University (Medical School)$43,040,912
- Gary B. Ruvkun · Massachusetts General Hospital$32,268,648
- Scott W Lowe · Sloan-Kettering Inst Can Research$27,556,396
- Judy Lieberman · Boston Children'S Hospital$25,876,315
- Ehud Isacoff · University Of California Berkeley$25,475,182
Research focus
Rna InterferenceVascular Endothelial Growth FactorsLysineRna-Induced Silencing ComplexTumorTumor GrowthHistidineIn VivoMediatingResponseGene TargetingTherapeutic TargetGene SilencingGenesCellsCleaved CellChemotherapyInhibitor/AntagonistAvastinMalignant NeoplasmsMonoclonal AntibodiesPolymersEpidermal Growth Factor ReceptorGene Expression
Grant awards (3)
MULTI-TARGETED RNAI THERAPEUTICS FOR GLIOBLASTOMA MULTIFORME (GBM)$269,298
R43 · FY2010 · CA · contact PI
MULTI-TARGETED RNAI THERAPEUTICS FOR TREATMENT OF LUNG CANCER (NSCLC)$250,000
R43 · FY2009 · CA · contact PI
Multi-targeted RNAi Therapeutic for Treatment of Breast Cancer$228,000
R43 · FY2008 · CA · contact PI